Ayodeji Adegunsoye, MD, PhD, MSc, professor of medicine at the University of Chicago Medicine, described the Clinical Year in Review (CYIR) series at the ATS 2026 International Conference as “signal-over-noise presentations that provide a carefully curated clinically-oriented session, distilling the recent year’s most important peer-reviewed articles or studies into formats that the attendees can easily grasp.”

Dr. Adegunsoye, with Arun Kannappan, MD, associate professor of medicine at the University of Colorado Anschutz, and Elisabeth Dianne Riviello, MD, MPH, assistant professor of medicine at Harvard Medical School/Beth Israel Deaconess Medical Center, is co-chairing the four CYIR sessions at the ATS 2026 International Conference.

Dr. Adegunsoye added, “The presentations in each of the CYIR sessions are delivered in engaging ways, usually by emerging leaders in the field, while also remaining cutting-edge and grounded in day-to-day clinical practice.”

This year’s presentations will cover precision approaches that incorporate biologics, endotypes risk scores, and optimal treat-to-target strategies. According to Dr. Adegunsoye, the overarching theme across presentations in the CYIR sessions is to empower clinicians with critical, timely information that positively affects patients’ disease trajectory, leveraging the right history and counseling in real-world practice.

“We will also be discussing earlier recognition and action, to help prevent detrimental outcomes for our patients — including screening, monitoring, responsible use of escalation pathways, and ways for minimizing invasive procedures and improving diagnostic yield and safety, where possible,” Dr. Adegunsoye said.

Tuesday’s CYIR session (the third of four sessions), from 9:15–10:45 a.m. on May 19 in the Chapin Theater (Level III, OCCC West Concourse), will focus on cystic fibrosis/non-cystic fibrosis bronchiectasis, interstitial lung disease, lung transplant, and occupational/environmental lung diseases.

Day three will begin with a focus on cystic fibrosis and then non-cystic fibrosis bronchiectasis, followed by interstitial lung disease (ILD).

Dr. Adegunsoye said, “ILD is a fast-moving field, and we have had new guidelines developed over the last year. In the ILD talk, we will emphasize early identification of progression and the best practical approaches to monitoring these patients.”

For the presentation on lung transplantation, Dr. Adegunsoye said the aim is to share evidence to support responsible candidate selection, achieve post-transplant outcomes that are meaningful to patients, and outline methods to improve early detection of deterioration and trigger escalation for lung transplant patients.

He added that the presentation on occupational and environmental lung disease would bring the session full circle on prevention, with a focus on identifying exposures as modifiable factors in disease progression and strategies for managing patients at risk/with exposure-related lung disease.

The final CYIR Series presentations will begin at 8:15 a.m. on Wednesday, May 20, in the Chapin Theater, with examinations of recent findings in COPD, interventional pulmonary medicine, medical education, and lung cancer.

Dr. Adegunsoye said that the COPD presentation will highlight how new evidence in this area affects day-to-day care for patients with COPD across diverse health systems, not just in the United States but globally.

The second talk on day four will spotlight studies on interventional pulmonary techniques, highlighting safety and diagnostic yield. Dr. Adegunsoye added that the presentation will also review the management of nodules that clinicians encounter in the clinic, as well as airway disease, and how to prevent harm when employing invasive procedures.

He also highlighted the addition of a medical education presentation in this year’s CYIR series.

“Medical education has not been featured in the CYIR session in recent years. This year, we will review not just the evidence, but how to implement evidence-supported methods practically and effectively, to improve clinicians’ performance,” Dr. Adegunsoye said.

The lung cancer presentation will explore the intersection of early detection, risk stratification, and practical workflows or algorithms that pulmonologists can implement immediately to improve patient outcomes, according to Dr. Adegunsoye.